BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Prognosis
7 results:

  • 1. MiR-4458-loaded gelatin nanospheres target COL11A1 for ddr2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
    Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
    Biomater Sci; 2022 Aug; 10(16):4596-4611. PubMed ID: 35792605
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
    Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
    Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
    Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor ddr2.
    Slocum E; Craig A; Villanueva A; Germain D
    Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
    Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
    PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tyrosine kinase discoidin domain receptors DDR1 and ddr2 are coordinately deregulated in triple-negative breast cancer.
    Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
    Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased expression of discoidin domain receptor 2 (ddr2): a novel independent prognostic marker of worse outcome in breast cancer patients.
    Ren T; Zhang J; Zhang J; Liu X; Yao L
    Med Oncol; 2013 Mar; 30(1):397. PubMed ID: 23307244
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.